- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01602263
Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing
Transcranial Direct Current Stimulation (tDCS)and Cognitive Processing
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants enrolled into this study may be asked to do the following:
- Grant permission for the researchers to view medical records associated with their language/cognitive difficulties (if applicable.
- Complete a questionnaire, provide a health history, and take some pencil-and-paper tests of problem-solving and memory in order to verify eligibility to participate and to able to safely undergo the experimental procedures.
- Complete several tasks (i.e., saying words out loud, naming objects, drawing designs, remembering lists of words, searching for images or letters, and/or completing puzzles) based upon a number of cognitive functions such as language, memory, vision, processing, and perception.
- Wear electrodes that will be placed on the scalp with a large rubberized band. These electrodes will administer very weak electrical current (tDCS) from a battery powered device for 20 to 60 minutes.
- Participation in several study conditions. The exact conditions and their order will be randomized. Under some conditions, participants may receive active stimulation (tDCS) and under other conditions, they may receive sham stimulation.
- The experimental sessions will last approximately 2 hours and participants may be asked to have more than one testing session in a day or to return for additional sessions.
- Have a Magnetic Resonance Imaging (MRI) brain scan.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21231
- Department of Neurology; Cognitive Neurology/Neuropsychology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
You must also belong to one of three groups to join this study:
- Healthy adults with no known deficits in cognition
- Adults with acquired language problems (i.e., stroke, mental illness)
- Adults with developmental language delays
Description
Eligibility Criteria by Study Group
Normal Controls Inclusion Criteria:
- Right handed (as determined by the Edinburgh battery)
- English as native language
Normal Controls Exclusion Criteria:
- Appreciable deficits in hearing
- Appreciable problems with articulation
- Schizophrenia, bipolar disorder, or major depression
- Appreciable accent
- Any neurological disorder associated with cognitive impairment or neuroanatomic abnormality
- Language-based learning disorder
- Any implanted metal device (precludes use of tDCS)
- Any implanted cardiac pacemaker
- Dementia or Mini-Mental State Exam < 24
- Estimated verbal intelligence < 70
Aphasia Group Inclusion Criteria:
- Right handed (as determined by the Edinburgh battery)
- English as native language
- History of acquired left-hemisphere dysfunction
Aphasia Group Exclusion Criteria:
- Appreciable deficits in hearing
- Schizophrenia, bipolar disorder, or major depression
- Appreciable accent
- Language-based learning disorder
- Any implanted metal device
- Any implanted cardiac pacemaker
- Mini-Mental State Exam < 21/27 (omitting naming & items)
- Estimated verbal intelligence < 70
Schizophrenia/First-degree Family Members Inclusion Criteria:
- Right handed (as determined by the Edinburgh battery)
- English as native language
- Diagnosis of schizophrenia (SZ) or bipolar disorder (BD)
- First degree family member of individual with SZ or BD
Schizophrenia/First-degree Family Members Exclusion Criteria:
- Appreciable deficits in hearing
- Appreciable accent
- Any implanted metal device (precludes use of tDCS)
- Any implanted cardiac pacemaker
- Dementia or Mini-Mental State Exam < 24
- Estimated verbal intelligence < 70
High-functioning Autism Inclusion Criteria:
- Right handed (as determined by the Edinburgh battery)
- English as native language
- Diagnosis of High-functioning autism (i.e., Asperger's)
High-functioning Autism Exclusion Criteria:
- Appreciable deficits in hearing
- Schizophrenia, bipolar disorder, or major depression
- Appreciable accent
- Any implanted metal device
- Any implanted cardiac pacemaker
- Dementia or Mini-Mental State Exam < 24
- Estimated verbal intelligence < 70
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Controls
Healthy Controls with no known cognitive impairment will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
|
Anodal, Cathodal or Sham tDCS.
|
|
Individuals with schizophrenia
Individuals with schizophrenia and first-degree relatives will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
|
Anodal, Cathodal or Sham tDCS.
|
|
Individuals with aphasia
Individuals with aphasia will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
|
Anodal, Cathodal or Sham tDCS.
|
|
Individuals with high-functioning autism
Individuals with high-functioning autism will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
|
Anodal, Cathodal or Sham tDCS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Indices of cognitive function
Time Frame: The average time frame is 1 hour
|
The average time frame is 1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Persistence of cognitive enhancements following tDCS
Time Frame: The average time frame is 1 hour
|
The average time frame is 1 hour
|
|
|
Initiation, endurance and cessation of skin sensations caused by tDCS
Time Frame: The average time frame is 1 hour
|
The initiation, endurance and cessation of skin sensations caused by tDCS will be examined in order to develop a more effective blinding procedure.
|
The average time frame is 1 hour
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Barry Gordon, M.D., Ph.D., Johns Hopkins University
Publications and helpful links
General Publications
- van Steenburgh JJ, Varvaris M, Schretlen DJ, Vannorsdall TD, Gordon B. Balanced bifrontal transcranial direct current stimulation enhances working memory in adults with high-functioning autism: a sham-controlled crossover study. Mol Autism. 2017 Jul 28;8:40. doi: 10.1186/s13229-017-0152-x. eCollection 2017.
- Vannorsdall TD, van Steenburgh JJ, Schretlen DJ, Jayatillake R, Skolasky RL, Gordon B. Reproducibility of tDCS Results in a Randomized Trial: Failure to Replicate Findings of tDCS-Induced Enhancement of Verbal Fluency. Cogn Behav Neurol. 2016 Mar;29(1):11-7. doi: 10.1097/WNN.0000000000000086.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NA_00015657
- 15657 (Other Identifier: Other)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Bradley LegaRecruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSchizophrenia Disorder
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on Transcranial Direct Current Stimulation (tDCS)
-
Charite University, Berlin, GermanyTerminatedNeuralgia | Neuropathic PainGermany
-
Manhattan Psychiatric CenterCompletedSchizophrenia | Auditory HallucinationUnited States
-
D'Or Institute for Research and EducationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted
-
Massachusetts General HospitalRecruitingAttention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
NYU Langone HealthNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingDepressionUnited States
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Charles University, Czech RepublicRecruiting
-
Minneapolis Veterans Affairs Medical CenterThe Defense and Veterans Brain Injury Center; Center for Veterans Research... and other collaboratorsActive, not recruitingTraumatic Brain Injury | ImpulsivityUnited States
-
United States Army Aeromedical Research LaboratoryCompletedTranscranial Direct Current StimulationUnited States
-
Washington University School of MedicineCompletedAnxiety | Depressive Symptoms | Cognitive Impairment, MildUnited States